SEARLE & CO. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEARLE & CO. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$49,000
-49.5%
20,000
-7.0%
0.02%
-53.5%
Q1 2021$97,000
-41.9%
21,500
-36.8%
0.04%
-46.2%
Q4 2020$167,000
+12.8%
34,000
-50.7%
0.08%
-7.0%
Q2 2020$148,000
+46.5%
69,000
+32.7%
0.09%
+19.4%
Q1 2020$101,00052,0000.07%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders